Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2017, Article ID 4176292, 12 pages
https://doi.org/10.1155/2017/4176292
Research Article

Canine Adipose Derived Mesenchymal Stem Cells Transcriptome Composition Alterations: A Step towards Standardizing Therapeutic

Virology Department, Croatian Veterinary Institute, Savska Cesta 143, 10,000 Zagreb, Croatia

Correspondence should be addressed to Nina Krešić; moc.oohay@omel.anin

Received 3 August 2016; Revised 19 December 2016; Accepted 4 January 2017; Published 26 January 2017

Academic Editor: Shimon Slavin

Copyright © 2017 Nina Krešić et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. Ullah, R. B. Subbarao, and G. J. Rho, “Human mesenchymal stem cells—current trends and future prospective,” Bioscience Reports, vol. 35, Article ID e00191, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. C. V. Machado, P. D. S. Telles, and I. L. O. Nascimento, “Immunological characteristics of mesenchymal stem cells,” Revista Brasileira de Hematologia e Hemoterapia, vol. 35, no. 1, pp. 62–67, 2013. View at Publisher · View at Google Scholar
  3. Y. Kfoury and D. T. Scadden, “Mesenchymal cell contributions to the stem cell niche,” Cell Stem Cell, vol. 16, no. 3, pp. 239–253, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Dominici, K. Le Blanc, I. Mueller et al., “Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement,” Cytotherapy, vol. 8, no. 4, pp. 315–317, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Screven, E. Kenyon, M. J. Myers et al., “Immunophenotype and gene expression profile of mesenchymal stem cells derived from canine adipose tissue and bone marrow,” Veterinary Immunology and Immunopathology, vol. 161, no. 1-2, pp. 21–31, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Takemitsu, D. Zhao, I. Yamamoto, Y. Harada, M. Michishita, and T. Arai, “Comparison of bone marrow and adipose tissue-derived canine mesenchymal stem cells,” BMC Veterinary Research, vol. 8, article no. 150, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. M. R. Schneider, E. Wolf, J. Braun, H.-J. Kolb, and H. Adler, “Canine embryo-derived stem cells and models for human diseases,” Human Molecular Genetics, vol. 17, no. 1, pp. R42–R47, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. I. H. Bellayr, J. G. Catalano, S. Lababidi et al., “Gene markers of cellular aging in human multipotent stromal cells in culture,” Stem Cell Research and Therapy, vol. 5, no. 2, article 59, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. W. Wagner, S. Bork, G. Lepperdinger et al., “How to track cellular aging of mesenchymal stromal cells?” Aging, vol. 2, no. 4, pp. 224–230, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. E. de Bakker, B. Van Ryssen, C. De Schauwer, and E. Meyer, “Canine mesenchymal stem cells: state of the art, perspectives as therapy for dogs and as a model for man,” Veterinary Quarterly, vol. 33, no. 4, pp. 225–233, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. O. Levy, W. Zhao, L. J. Mortensen et al., “mRNA-engineered mesenchymal stem cells for targeted delivery of interleukin-10 to sites of inflammation,” Blood, vol. 122, no. 14, pp. e23–e32, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Kyurkchiev, “Secretion of immunoregulatory cytokines by mesenchymal stem cells,” World Journal of Stem Cells, vol. 6, no. 5, p. 552, 2014. View at Publisher · View at Google Scholar
  13. G. Q. Daley, “The promise and perils of stem cell therapeutics,” Cell Stem Cell, vol. 10, no. 6, pp. 740–749, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. R. C. Zhao, “Essentials of mesenchymal stem cell biology and its clinical translation,” Essentials of Mesenchymal Stem Cell Biology and Its Clinical Translation, pp. 1–313, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Martinello, I. Bronzini, L. Maccatrozzo et al., “Canine adipose-derived-mesenchymal stem cells do not lose stem features after a long-term cryopreservation,” Research in Veterinary Science, vol. 91, no. 1, pp. 18–24, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Kuilman, C. Michaloglou, W. J. Mooi, and D. S. Peeper, “The essence of senescence,” Genes and Development, vol. 24, no. 22, pp. 2463–2479, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. L. J. Fick, G. H. Fick, Z. Li et al., “Telomere length correlates with life span of dog breeds,” Cell Reports, vol. 2, no. 6, pp. 1530–1536, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. D. T. Loo, J. I. Fuquay, C. L. Rawson, and D. W. Barnes, “Extended culture of mouse embryo cells without senescence: inhibition by serum,” Science, vol. 236, no. 4798, pp. 200–202, 1987. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Parrinello, E. Samper, A. Krtolica, J. Goldstein, S. Melov, and J. Campisi, “Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts,” Nature Cell Biology, vol. 5, no. 8, pp. 741–747, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. M. S. Choudhery, M. Badowski, A. Muise, J. Pierce, and D. T. Harris, “Donor age negatively impacts adipose tissue-derived mesenchymal stem cell expansion and differentiation,” Journal of Translational Medicine, vol. 12, no. 1, article no. 8, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Neupane, C.-C. Chang, M. Kiupel, and V. Yuzbasiyan-Gurkan, “Isolation and characterization of canine adipose-derived mesenchymal stem cells,” Tissue Engineering - Part A., vol. 14, no. 6, pp. 1007–1015, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. Y.-T. Xiao, L.-X. Xiang, and J.-Z. Shao, “Bone morphogenetic protein,” Biochemical and Biophysical Research Communications, vol. 362, no. 3, pp. 550–553, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Pairault and H. Green, “A study of the adipose conversion of suspended 3T3 cells by using glycerophosphate dehydrogenase as differentiation marker,” Proceedings of the National Academy of Sciences of the United States of America, vol. 76, no. 10, pp. 5138–5142, 1979. View at Publisher · View at Google Scholar · View at Scopus
  24. K. L. Pricola, N. Z. Kuhn, H. Haleem-Smith, Y. Song, and R. S. Tuan, “Interleukin-6 maintains bone marrow-derived mesenchymal stem cell stemness by an ERK1/2-dependent mechanism,” Journal of Cellular Biochemistry, vol. 108, no. 3, pp. 577–588, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. W. Wagner, P. Horn, M. Castoldi et al., “Replicative senescence of mesenchymal stem cells: a continuous and organized process,” PLOS ONE, vol. 3, no. 5, Article ID e2213, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. I. Roato, D. Alotto, D. C. Belisario et al., “Adipose Derived-mesenchymal stem cells viability and differentiating features for orthopaedic reparative applications: banking of adipose tissue,” Stem Cells International, vol. 2016, Article ID 4968724, 11 pages, 2016. View at Publisher · View at Google Scholar
  27. F. J. Lv, R. S. Tuan, K. M. Cheung, and V. Y. Leung, “Concise review: the surface markers and identity of human mesenchymal stem cells,” Stem Cells, vol. 32, no. 6, pp. 1408–1419, 2014. View at Publisher · View at Google Scholar
  28. T. C. Barnes, M. E. Anderson, and R. J. Moots, “The many faces of interleukin-6: the role of IL-6 in inflammation, vasculopathy, and fibrosis in systemic sclerosis,” International Journal of Rheumatology, vol. 2011, Article ID 721608, 6 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. C. A. Hunter and S. A. Jones, “IL-6 as a keystone cytokine in health and disease,” Nature Immunology, vol. 16, no. 5, pp. 448–457, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. S. M. Melief, S. B. Geutskens, W. E. Fibbe, and H. Roelofs, “Multipotent stromal cells skew monocytes towards an anti-inflammatory interleukin-10-producing phenotype by production of interleukin-6,” Haematologica, vol. 98, no. 6, pp. 888–895, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. S.-M. Han, S.-H. Han, Y.-R. Coh et al., “Enhanced proliferation and differentiation of Oct4- And Sox2-overexpressing human adipose tissue mesenchymal stem cells,” Experimental and Molecular Medicine, vol. 46, no. 6, article e101, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. V. N. Anisimov, “The relationship between aging and carcinogenesis: a critical appraisal,” Critical Reviews in Oncology/Hematology, vol. 45, no. 3, pp. 277–304, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. J. P. De Magalhães, “How ageing processes influence cancer,” Nature Reviews Cancer, vol. 13, no. 5, pp. 357–365, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. B. D. Smith, G. L. Smith, A. Hurria, G. N. Hortobagyi, and T. A. Buchholz, “Future of cancer incidence in the United States: burdens upon an aging, changing nation,” Journal of Clinical Oncology, vol. 27, no. 17, pp. 2758–2765, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Yancik, “Population aging and cancer: a cross-national concern,” Cancer Journal, vol. 11, no. 6, pp. 437–441, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. P. D. Adams, H. Jasper, and K. L. Rudolph, “Aging-induced stem cell mutations as drivers for disease and cancer,” Cell Stem Cell, vol. 16, no. 6, pp. 601–612, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. J.-O. Jeong, J. W. Han, J.-M. Kim et al., “Malignant tumor formation after transplantation of short-term cultured bone marrow mesenchymal stem cells in experimental myocardial infarction and diabetic neuropathy,” Circulation Research, vol. 108, no. 11, pp. 1340–1347, 2011. View at Publisher · View at Google Scholar · View at Scopus